跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANOLAZINA AUROVITAS 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RANOLAZINA AUROVITAS 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
RANOLAZINA AUROVITAS 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 21, 2026
Approval ID
2e6cc44224c0fa07
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
2e6cc44224c0fa07
Drug Cima Aemps Name
RANOLAZINA AUROVITAS 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
91576
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2026-08-21
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
750 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Aurovitas Spain, S.A.U.
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 21, 2026
Approval ID
2e6cc44224c0fa07
Type
Standard
Back to CIMA-AEMPS Approvals